ロード中...
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
Purpose: Pancreatic ductal adenocarcinoma (PDAC) with difficulty in early diagnosis does not respond well to conventional treatments and has not occurred significant improvement in the overall 5-year survival rates. Mesothelin (MSLN) is a tumor differentiation antigen expressed in several solid neop...
保存先:
| 出版年: | Int J Med Sci |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7053310/ https://ncbi.nlm.nih.gov/pubmed/32174772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.39012 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|